Protective and curative potential of vaccination with interleukin-2-gene-transfected cells from a spontaneous mouse mammary adenocarcinoma

Federica Cavallo, Francesco Di Pierro, Mirella Giovarelli, Alberto Gulino, Alessandra Vacca, Antonella Stoppacciaro, Marco Forni, Andrea Modesti, Guido Forni

Research output: Contribution to journalArticle

93 Citations (Scopus)

Abstract

The potential of interleukin 2-gene-transfected tumor cells to prevent tumor growth and cure established tumors was evaluated using cells from a spontaneous, invasive, and metastasizing mouse mammary adenocarcinoma. Tumor cells engineered to secrete interleukin 2 initially trigger a local inflammatory reaction that leads to inhibition of established parental adenocarcinomas, as well as an antigenically unrelated fibrosarcoma. The ensuing systemic immunity selectively inhibits subsequent parental cell challenges and cures established parental adenocarcinomas and their lung metastases, although less effectively as the neoplastic mass increases. Multiple injections of interleukin 2-gene-transfected tumor cells may thus be considered a new form of vaccination in the management of minimal residual disease and incipient metastases.

Original languageEnglish
Pages (from-to)5067-5070
Number of pages4
JournalCancer Research
Volume53
Issue number21
Publication statusPublished - Nov 1 1993

Fingerprint

Interleukin-2
Vaccination
Adenocarcinoma
Breast
Genes
Neoplasms
Neoplasm Metastasis
Fibrosarcoma
Residual Neoplasm
Immunity
Injections
Growth

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Cavallo, F., Di Pierro, F., Giovarelli, M., Gulino, A., Vacca, A., Stoppacciaro, A., ... Forni, G. (1993). Protective and curative potential of vaccination with interleukin-2-gene-transfected cells from a spontaneous mouse mammary adenocarcinoma. Cancer Research, 53(21), 5067-5070.

Protective and curative potential of vaccination with interleukin-2-gene-transfected cells from a spontaneous mouse mammary adenocarcinoma. / Cavallo, Federica; Di Pierro, Francesco; Giovarelli, Mirella; Gulino, Alberto; Vacca, Alessandra; Stoppacciaro, Antonella; Forni, Marco; Modesti, Andrea; Forni, Guido.

In: Cancer Research, Vol. 53, No. 21, 01.11.1993, p. 5067-5070.

Research output: Contribution to journalArticle

Cavallo, F, Di Pierro, F, Giovarelli, M, Gulino, A, Vacca, A, Stoppacciaro, A, Forni, M, Modesti, A & Forni, G 1993, 'Protective and curative potential of vaccination with interleukin-2-gene-transfected cells from a spontaneous mouse mammary adenocarcinoma', Cancer Research, vol. 53, no. 21, pp. 5067-5070.
Cavallo F, Di Pierro F, Giovarelli M, Gulino A, Vacca A, Stoppacciaro A et al. Protective and curative potential of vaccination with interleukin-2-gene-transfected cells from a spontaneous mouse mammary adenocarcinoma. Cancer Research. 1993 Nov 1;53(21):5067-5070.
Cavallo, Federica ; Di Pierro, Francesco ; Giovarelli, Mirella ; Gulino, Alberto ; Vacca, Alessandra ; Stoppacciaro, Antonella ; Forni, Marco ; Modesti, Andrea ; Forni, Guido. / Protective and curative potential of vaccination with interleukin-2-gene-transfected cells from a spontaneous mouse mammary adenocarcinoma. In: Cancer Research. 1993 ; Vol. 53, No. 21. pp. 5067-5070.
@article{94977f2ad330406994638c6efc9a5074,
title = "Protective and curative potential of vaccination with interleukin-2-gene-transfected cells from a spontaneous mouse mammary adenocarcinoma",
abstract = "The potential of interleukin 2-gene-transfected tumor cells to prevent tumor growth and cure established tumors was evaluated using cells from a spontaneous, invasive, and metastasizing mouse mammary adenocarcinoma. Tumor cells engineered to secrete interleukin 2 initially trigger a local inflammatory reaction that leads to inhibition of established parental adenocarcinomas, as well as an antigenically unrelated fibrosarcoma. The ensuing systemic immunity selectively inhibits subsequent parental cell challenges and cures established parental adenocarcinomas and their lung metastases, although less effectively as the neoplastic mass increases. Multiple injections of interleukin 2-gene-transfected tumor cells may thus be considered a new form of vaccination in the management of minimal residual disease and incipient metastases.",
author = "Federica Cavallo and {Di Pierro}, Francesco and Mirella Giovarelli and Alberto Gulino and Alessandra Vacca and Antonella Stoppacciaro and Marco Forni and Andrea Modesti and Guido Forni",
year = "1993",
month = "11",
day = "1",
language = "English",
volume = "53",
pages = "5067--5070",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "21",

}

TY - JOUR

T1 - Protective and curative potential of vaccination with interleukin-2-gene-transfected cells from a spontaneous mouse mammary adenocarcinoma

AU - Cavallo, Federica

AU - Di Pierro, Francesco

AU - Giovarelli, Mirella

AU - Gulino, Alberto

AU - Vacca, Alessandra

AU - Stoppacciaro, Antonella

AU - Forni, Marco

AU - Modesti, Andrea

AU - Forni, Guido

PY - 1993/11/1

Y1 - 1993/11/1

N2 - The potential of interleukin 2-gene-transfected tumor cells to prevent tumor growth and cure established tumors was evaluated using cells from a spontaneous, invasive, and metastasizing mouse mammary adenocarcinoma. Tumor cells engineered to secrete interleukin 2 initially trigger a local inflammatory reaction that leads to inhibition of established parental adenocarcinomas, as well as an antigenically unrelated fibrosarcoma. The ensuing systemic immunity selectively inhibits subsequent parental cell challenges and cures established parental adenocarcinomas and their lung metastases, although less effectively as the neoplastic mass increases. Multiple injections of interleukin 2-gene-transfected tumor cells may thus be considered a new form of vaccination in the management of minimal residual disease and incipient metastases.

AB - The potential of interleukin 2-gene-transfected tumor cells to prevent tumor growth and cure established tumors was evaluated using cells from a spontaneous, invasive, and metastasizing mouse mammary adenocarcinoma. Tumor cells engineered to secrete interleukin 2 initially trigger a local inflammatory reaction that leads to inhibition of established parental adenocarcinomas, as well as an antigenically unrelated fibrosarcoma. The ensuing systemic immunity selectively inhibits subsequent parental cell challenges and cures established parental adenocarcinomas and their lung metastases, although less effectively as the neoplastic mass increases. Multiple injections of interleukin 2-gene-transfected tumor cells may thus be considered a new form of vaccination in the management of minimal residual disease and incipient metastases.

UR - http://www.scopus.com/inward/record.url?scp=0027487856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027487856&partnerID=8YFLogxK

M3 - Article

VL - 53

SP - 5067

EP - 5070

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 21

ER -